Validation Data Gallery
Tested Applications
| Positive WB detected in | NIH/3T3 cells, mouse testis tissue, A549 cells, rat brain tissue, HepG2 cells | 
| Positive IP detected in | mouse brain tissue | 
| Positive IHC detected in | human lung cancer tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 | 
| Positive IF/ICC detected in | HepG2 cells | 
Recommended dilution
| Application | Dilution | 
|---|---|
| Western Blot (WB) | WB : 1:1000-1:8000 | 
| Immunoprecipitation (IP) | IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate | 
| Immunohistochemistry (IHC) | IHC : 1:50-1:500 | 
| Immunofluorescence (IF)/ICC | IF/ICC : 1:1500-1:6000 | 
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Published Applications
| KD/KO | See 1 publications below | 
| WB | See 11 publications below | 
| IF | See 5 publications below | 
| RIP | See 1 publications below | 
Product Information
20371-1-AP targets SFRS2 in WB, IHC, IF/ICC, IP, RIP, ELISA applications and shows reactivity with human, mouse, rat samples.
| Tested Reactivity | human, mouse, rat | 
| Cited Reactivity | human, mouse, rat | 
| Host / Isotype | Rabbit / IgG | 
| Class | Polyclonal | 
| Type | Antibody | 
| Immunogen | Peptide相同性解析による交差性が予測される生物種 | 
| Full Name | splicing factor, arginine/serine-rich 2 | 
| Calculated molecular weight | 25 kDa | 
| Observed molecular weight | 25-35 kDa | 
| GenBank accession number | NM_003016 | 
| Gene Symbol | SFRS2 | 
| Gene ID (NCBI) | 6427 | 
| RRID | AB_2616311 | 
| Conjugate | Unconjugated | 
| Form | |
| Form | Liquid | 
| Purification Method | Antigen affinity purification | 
| UNIPROT ID | Q01130 | 
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol{{ptg:BufferTemp}}7.3 | 
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. | 
Background Information
SFRS2, also named as PR264 and Splicing component, 35 kDa, belongs to the splicing factor SR family. SFRS2 is necessary for the splicing of pre-mRNA. Some residue of SFRS2 is modified by phosphorylase and acetylase after translation. The molecular weight of modified SFRS2 is 35-40kDa. It is required for formation of the earliest ATP-dependent splicing complex and interacts with spliceosomal components bound to both the 5'- and 3'-splice sites during spliceosome assembly. It also is required for ATP-dependent interactions of both U1 and U2 snRNPs with pre-mRNA. It binds to purine-rich RNA sequences, either 5'-AGSAGAGTA-3' (S=C or G) or 5'-GTTCGAGTA-3'. SFRS2 can bind to beta-globin mRNA and commit it to the splicing pathway. The antibody has no cross reaction to SFRS2B.
Protocols
| Product Specific Protocols | |
|---|---|
| IF protocol for SFRS2 antibody 20371-1-AP | Download protocol | 
| IHC protocol for SFRS2 antibody 20371-1-AP | Download protocol | 
| IP protocol for SFRS2 antibody 20371-1-AP | Download protocol | 
| WB protocol for SFRS2 antibody 20371-1-AP | Download protocol | 
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols | 
Publications
| Species | Application | Title | 
|---|---|---|
| Nat Commun Mutually exclusive acetylation and ubiquitylation of the splicing factor SRSF5 control tumor growth. | ||
| EMBO Mol Med SRSF protein kinase 1 modulates RAN translation and suppresses CGG repeat toxicity | ||
| Int J Biol Macromol 5-Methylcytosine-modified circRNA-CCNL2 regulates vascular remdeling in hypoxic pulmonary hypertension through binding to FXR2 | ||
| Am J Cancer Res tRF-20-M0NK5Y93-induced MALAT1 promotes colon cancer metastasis through alternative splicing of SMC1A
 | ||
| J Biol Chem Proteomic study identifies Aurora-A mediated regulation of alternative splicing through multiple splicing factors | ||
| Neuroscience The Age-dependent Elevation of miR-335-3p Leads to Reduced Cholesterol and Impaired Memory in Brain. | 








